Laboratorios Farmaceuticos Rovi
ROVI.MC
#3670
Rank
NZ$6.47 B
Marketcap
NZ$126.56
Share price
-4.54%
Change (1 day)
4.46%
Change (1 year)

EPS for Laboratorios Farmaceuticos Rovi (ROVI.MC)

EPS in 2026 (TTM): NZ$4.91

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current EPS (TTM) is NZ$5.11. In 2025 the company made an earnings per share (EPS) of NZ$5.91 an increase over its 2024 EPS that were of NZ$5.09.

EPS history for Laboratorios Farmaceuticos Rovi from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.91-16.8%
2025NZ$5.9116.01%
2024NZ$5.09-23.36%
2023NZ$6.64-9.18%
2022NZ$7.3128.01%
2021NZ$5.71131.02%
2020NZ$2.4770.11%
2019NZ$1.4598.64%
2018NZ$0.73-4.66%
2017NZ$0.77-24.67%
2016NZ$1.0227.47%
2015NZ$0.80-25.08%
2014NZ$1.07-8.1%
2013NZ$1.1623.14%
2012NZ$0.9410.35%
2011NZ$0.85-28.27%
2010NZ$1.1910.96%
2009NZ$1.072.4%
2008NZ$1.0530.95%
2007NZ$0.80268.85%
2006NZ$0.22